The Canadian Psychedelic Businesses Association

We are
PsyCan

A not-for-profit trade association representing Canadian psychedelic medicine and therapy companies.

About Us

Press Release — Nov 08, 2023

Canadian Psychedelic Trade Association Endorses Senate Report Calling for Research into Psychedelic-Assisted Therapy

Read

Press Release — Oct 03, 2023

The Future of Psychedelic Access in Canada: PsyCan Releases White Paper Reviewing Regulatory Options for Psychedelics

Read

News Item — Jul 17, 2023

Empower Psychedelics preparing for clinical trials through the Special Access Program

Read

Psychedelics for mental health care

We champion the benefits of scientifically-proven, psychedelic-assisted therapies administered by qualified practitioners to Canadians suffering from chronic mental health conditions.

Newsroom

Advancing the psychedelics industry

We are dedicated to advocating on behalf of, and improving the regulatory landscape for, the legal psychedelics industry in Canada.

About us

Become a member

We represent researchers, medical practitioners, labs, clinics, drug developers, and suppliers producing and working with psychedelic medicine.

Membership

Leading the
charge for change

Our members are some of Canada’s industry leaders in pharmaceuticals, psychedelics, and mental health research. Together we seek to educate and better understand how psychedelics can improve mental health outcomes and well-being.

More about our members